Jesse W. Mosier’s practice focuses on international corporate and financial transactions, particularly cross-border restructurings, mergers and acquisitions and capital markets offerings, with an emphasis on Latin America.
Jesse joined the firm in 2012. From 2012 to 2014, he was resident in the New York office.
- The steering committee of an ad hoc group of bondholders and a group of backstop commitment providers of Oi S.A. in the judicial restructuring of approximately $20 billion of the company’s debt, the largest private sector debt restructuring in Latin American history.
- An ad hoc group of secured and unsecured bondholders of, and the providers of a new $70 million secured loan facility to Tonon Bioenergia in connection with Tonon’s voluntary exchange offer for its $300 million unsecured bonds.
- An ad hoc group of secured and unsecured bondholders and secured lenders of Tonon Bioenergia in the judicial restructuring of more than $900 million of the Tonon’s debt, including the sale by Tonon of an unidade produtiva isolada (UPI) consisting of two of the company’s three sugar cane processing mills to Raizen, with proceeds of the sale distributed to creditors.
- Votorantim S.A. and Votorantim Metais S.A. in the reorganization of Votorantim’s zinc and nickel mining and processing businesses under a Luxembourg holding company, VM Holding S.A. (now Nexa Resources S.A.), including advising Votorantim on increasing its stake in Compañía Minera Milpo, a Peruvian listed mining corporation, from approximately 51 percent to 80 percent in a series of transactions over the Lima stock exchange, and the entry of new third party investors in VM Holding.
- JPMorgan Asset Management in the sale of its entire stake in Gávea Investimentos, a Brazilian investment management firm, to Gávea’s original founders.
- América Móvel in multiple registered and unregistered capital markets transactions, its spin-off of Telesites SAB, and related to its minority investments in KPN, Telekom Austria, Mobli Media and Sport 195.
- BTG Pactual and Santander as underwriters in a follow-on offering by Brasil Pharma of R$400 million (approximately $100 million) in common shares pursuant to the Brazilian SEC’s Rule 476.
- Georgetown University Law Center, J.D., 2012
- New York University, B.A., 2006
- Tufts University, M.A.L.D.
- New York
Rate : $$$$